ProjectUpdated on 25 August 2025
A breakthrough therapy project for the treatment of neurodegeneration to unlock a $60B+ market
About
SunRegen is a Swiss biopharmaceutical pioneer developing the world’s first oral neuro-rescuing therapy with the potential to treat retinal and CNS neurodegenerative diseases. Backed by Nobel-recognized science, robust preclinical data, and a $60B+ market opportunity, SBC003 represents a rare investment opportunity to support a first-in-class therapy with super blockbuster potential.
Project Location
- Switzerland
Project Format
- Private Project
ESG (Environmental, Social, and Governance)
- No
Project Stage
- Feasibility Study Completed
Main Project Sector
- Technology
Technology
- Health Technology
Total Project Value
- 50,000,001 USD or above
Investment Capital Required
- 10,000,001 to 25,000,000 USD
Interested Format of Cooperation
- Joint Venture
- Open for Negotiation
- R&D Cooperation
Preferred Financing Model
- Equity
- Open for negotiation
Previous Funding Stage
- Seed & Pre-Series
Return on Investment
200
Main Service(s) Required
- Professional Services
Attached files
Organisation
Reinach, Switzerland
Similar opportunities
Project
SVGTS is our RES project that has no analogues in the world
- Yes
- None
- Technology
- Wind Energy
- Solar Energy
- Manufacturing
- Joint Venture
- Private Project
- Hydrogen Energy
- Energy Management
- Open for Negotiation
- Open for negotiation
- Other Renewable Energy
- Environmental Services
- Feasibility Study Completed
- Energy and Natural Resources
- 10,000,001 to 25,000,000 USD
- 10,000,001 to 25,000,000 USD
Nurlan Abdullaev
CEO at MDN group Ltd
Bishkek, Kyrgyzstan
Project
INDUSTRIAL PARK DEVELOPMENT IN MEXICO
- Yes
- None
- Construction
- Manufacturing
- Private Project
- Industrial Parks
- Open for Negotiation
- Open for negotiation
- Infrastructure Services
- Building & Construction
- Construction Engineering
- 10,000,001 to 25,000,000 USD
- Transport and Logistics Infrastructure
Susana Munoz
Managing Partner at GBA LATAM TRADE AND INVESTMENT ADVISORS
Hong Kong, China
Project
- Yes
- Equity
- Technology
- Private Project
- Urban Development
- Seed & Pre-Series
- Financial Services
- Open for Negotiation
- 2,500,001 to 5,000,000 USD
- Feasibility Study Completed
- 25,000,001 to 50,000,000 USD
Kelly luk
CFO at 诺科达智驾
香港, China (Hong Kong)